Suppr超能文献

结节病相关性肺动脉高压:阿拉伯患者的临床特征和结局。

Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients.

机构信息

Department of Medicine, Pulmonary Division, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.

出版信息

Ann Thorac Med. 2010 Apr;5(2):86-91. doi: 10.4103/1817-1737.62471.

Abstract

BACKGROUND

Pulmonary hypertension (PH) occurs in many patients with interstitial lung disease, including sarcoidosis. We explored the frequency, clinical characteristics and outcomes of PH in Arab patients diagnosed with pulmonary sarcoidosis.

METHODS

A retrospective study in three tertiary hospitals was performed on 96 patients who underwent Doppler echocardiography. Demographic and clinical characteristics, physiological studies and computed tomography (CT) results were collected, and compared between patients with and without PH.

RESULTS

Twenty (20.8%) patients were found to have PH. Patients with PH were more likely to be symptomatic (cough, P = 0.008; dyspnea, P = 0.04), to have an advanced radiographic stage (P = 0.001), and to be receiving systemic therapy (P = 0.001), compared to those without PH. Physiological data including pulmonary function test parameters, arterial blood gas levels and oxygen saturation at rest and after exercise were all significantly lower in patients with PH compared to those without PH. Comparison of CT patterns between patients with and without PH showed significant differences in the frequencies of ground-glass opacity (61.5 vs. 28.8%, P = 0.032) and fibrosis (76.9 vs. 44.2%, P = 0.035). In total, four patients died during the study period, including three with evidence of PH.

CONCLUSIONS

The frequency of PH in the present study was 20.8%. Clinical, physiologic and radiographic characteristics appeared to differentiate patients with PH from those without PH. The presence of PH contributed to poor outcomes in patients with pulmonary sarcoidosis.

摘要

背景

肺动脉高压(PH)发生于许多间质性肺疾病患者中,包括结节病。我们探讨了在被诊断为肺结节病的阿拉伯患者中 PH 的频率、临床特征和结局。

方法

对在三家三级医院接受多普勒超声心动图检查的 96 例患者进行了回顾性研究。收集了人口统计学和临床特征、生理研究和计算机断层扫描(CT)结果,并比较了有和无 PH 患者之间的差异。

结果

20 例(20.8%)患者存在 PH。与无 PH 患者相比,有 PH 的患者更可能有症状(咳嗽,P = 0.008;呼吸困难,P = 0.04),放射学分期更晚期(P = 0.001),并接受全身治疗(P = 0.001)。与无 PH 患者相比,有 PH 患者的生理数据,包括肺功能检查参数、动脉血气水平和静息及运动后氧饱和度均显著更低。有和无 PH 患者 CT 模式比较显示,磨玻璃影(61.5% vs. 28.8%,P = 0.032)和纤维化(76.9% vs. 44.2%,P = 0.035)的频率存在显著差异。研究期间共有 4 例患者死亡,其中 3 例有 PH 证据。

结论

本研究中 PH 的频率为 20.8%。临床、生理和放射学特征似乎可将 PH 患者与无 PH 患者区分开来。PH 的存在导致肺结节病患者的结局较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef5/2883203/dd69f7c400f8/ATM-05-86-g001.jpg

相似文献

1
Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients.
Ann Thorac Med. 2010 Apr;5(2):86-91. doi: 10.4103/1817-1737.62471.
2
Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
Int J Tuberc Lung Dis. 2013 Mar;17(3):406-11. doi: 10.5588/ijtld.12.0428.
3
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
Chest. 2006 May;129(5):1246-52. doi: 10.1378/chest.129.5.1246.
5
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.
Thorax. 2006 Jan;61(1):68-74. doi: 10.1136/thx.2005.042838. Epub 2005 Oct 14.
6
Pulmonary hypertension in chronic lung diseases.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036.
8
The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):317-320.
10

引用本文的文献

1
Sarcoidosis-Associated Pulmonary Hypertension.
J Clin Med. 2024 Apr 2;13(7):2054. doi: 10.3390/jcm13072054.
2
Sarcoidosis Associated Pulmonary Hypertension.
Biomedicines. 2024 Jan 13;12(1):177. doi: 10.3390/biomedicines12010177.
3
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
Respir Res. 2022 Jun 25;23(1):169. doi: 10.1186/s12931-022-02094-7.
4
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
Eur Respir Rev. 2022 Feb 9;31(163). doi: 10.1183/16000617.0165-2021. Print 2022 Mar 31.
5
Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
Front Cardiovasc Med. 2022 Jan 17;8:809594. doi: 10.3389/fcvm.2021.809594. eCollection 2021.
6
Pulmonary hypertension in patients with sarcoidosis: A single-center experience.
Anatol J Cardiol. 2021 Jan;25(1):36-41. doi: 10.14744/AnatolJCardiol.2020.88054.
7
Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):234-238. doi: 10.36141/svdld.v37i2.9343. Epub 2020 Jun 30.
8
Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension.
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):184-191. doi: 10.36141/svdld.v37i2.9150. Epub 2020 Jun 30.
9
Patient reported outcome measures (PROMs) in sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):2-17. doi: 10.36141/svdld.v34i1.5760. Epub 2017 Apr 28.
10
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.
Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26-e51. doi: 10.1164/rccm.202002-0251ST.

本文引用的文献

1
The six-minute walk test in patients with pulmonary sarcoidosis.
Ann Thorac Med. 2009 Apr;4(2):60-4. doi: 10.4103/1817-1737.49414.
2
Clinical predictors of pulmonary hypertension in sarcoidosis.
Eur Respir J. 2008 Aug;32(2):296-302. doi: 10.1183/09031936.00175907. Epub 2008 Apr 2.
3
Pulmonary hypertension in sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):108-16.
4
Clinical presentation of sarcoidosis in a mixed population in the middle east.
Respir Med. 2007 Nov;101(11):2284-8. doi: 10.1016/j.rmed.2007.06.025. Epub 2007 Aug 13.
5
Six-minute walk test and health status assessment in sarcoidosis.
Chest. 2007 Jul;132(1):207-13. doi: 10.1378/chest.06-2822.
6
Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis.
Chest. 2006 Nov;130(5):1496-502. doi: 10.1378/chest.130.5.1496.
7
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
Chest. 2006 May;129(5):1246-52. doi: 10.1378/chest.129.5.1246.
9
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.
Thorax. 2006 Jan;61(1):68-74. doi: 10.1136/thx.2005.042838. Epub 2005 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验